This compound is primarily utilized in the field of targeted protein degradation, specifically for research involving estrogen-related receptor alpha (ERRα). It functions as a key component in Proteolysis-Targeting Chimeras (PROTACs), which are designed to induce the degradation of ERRα by recruiting E3 ubiquitin ligases. This approach is valuable in studying ERRα's role in various biological processes, including metabolism, energy homeostasis, and cancer progression. By degrading ERRα, researchers can explore its functional significance and potential as a therapeutic target in diseases where ERRα is dysregulated, such as certain cancers and metabolic disorders. Its application is largely confined to preclinical studies, aiding in the development of novel therapeutic strategies.